Bio-Techne expands AI-engineered protein portfolio for cell therapy

🌐 Investing.com (CY) — 2026-07-08

Bio-Techne is expanding its AI-engineered protein portfolio aimed at enhancing cell therapy development. This advancement integrates artificial intelligence to improve protein engineering for medical applications.

Deals Health AI & Tech Bio-Techne AI-engineered proteins cell therapy biotech artificial intelligence

Read original source →

Syntiant Seeks IPO For Edge AI Chip Plan
Seeking Alpha — 2026-07-09
Barcelona’s bid for Bundesliga speedster stands at €20 million plus €10 million add-ons – report
Yahoo Sports — 2026-07-09
Russia ready for tech partnerships with friendly states — Prime Minister
TASS — 2026-07-09
SC Freiburg phenom headed to Newcastle United
Yahoo Sports — 2026-07-09
Fugro lands survey role on UK’s first offshore CO2 storage project
Splash247 Maritime — 2026-07-09
Galatasaray join race to sign Real Madrid talent amid uncertain future – report
Yahoo Sports — 2026-07-09

Bio-Techne expands AI-engineered protein portfolio for cell therapy

AI Summary

Related Articles

Syntiant Seeks IPO For Edge AI Chip Plan

Barcelona&#8217;s bid for Bundesliga speedster stands at €20 million plus €10 million add-ons &#8211; report

Russia ready for tech partnerships with friendly states — Prime Minister

SC Freiburg phenom headed to Newcastle United

Fugro lands survey role on UK’s first offshore CO2 storage project

Galatasaray join race to sign Real Madrid talent amid uncertain future &#8211; report

Barcelona’s bid for Bundesliga speedster stands at €20 million plus €10 million add-ons – report

Galatasaray join race to sign Real Madrid talent amid uncertain future – report